Latest Breaking News On - Ellen lubman - Page 2 : comparemela.com

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting

Werewolf Therapeutics Presents Preclinical Results Demonstrating Anti-Tumor Effects of Pro-Inflammatory Cytokine Therapeutics WTX-518 and WTX-712 at AACR 2024 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoEllen lubmanDanielj hicklinJosh rappaportCompany contactAmerican association for cancer researchExchange commissionWerewolf therapeutics incScientific communicationsCompany or werewolf nasdaqPro inflammatory cytokine therapeuticsAmerican associationCancer researchAnnual meetingChief executive officer

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting

Werewolf Therapeutics to Present First-of-Its-Kind Data Demonstrating Utility for PREDATOR™ Platform in Immunology-Based Diseases at AAI Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesDanielj hicklinJosh rappaportEllen lubmanCompany contactScientific communicationsCompany or werewolf nasdaqExchange commissionWerewolf therapeutics incAmerican association of immunologistsImmunology based diseasesWerewolf therapeuticsAmerican associationChief executive officerNon hodgkin lymphomaPrivate securities litigation reform act

Werewolf Therapeutics Appoints Michael Atkins, M D , to its Board of Directors

04.01.2024 - WATERTOWN, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) - Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of novel, conditionally activated INDUKINE therapeutics .

United statesWilliamm schollEllen lubmanMichael atkinsMelanoma research alliance medical advisory panelSociety for the immunotherapy of cancerVerge scientific communicationsProfessor at harvard medical schoolAdvisory councilCancer centerWerewolf therapeutics incCompany contactAcademy of immunooncologyWerewolf boardDeputy directorGeorgetown lombardi comprehensive cancer center

Cytovation Announces Appointment of Ellen Lubman, MBA to its Board of Directors

Bergen, Norway, December 20, 2023 – Cytovation ASA, a clinical stage immune-oncology company focused on the development of its first-in-class targ.

New jerseyUnited statesFederico gregoStein christian mohnEllen lubmanBristol myers squibbRobertson stephens investment bankRed door communityGilda clubStanford graduate school of businessDaedalus innovation fund of weill cornellBoard of directors reunion neuroscience incUniversity of bergen norwayImpel neuropharma incAbbott labsRutgers college

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference – IT Business Net

Werewolf Therapeutics to Present at the Evercore ISI HealthCONx Conference – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesRandi isaacsEllen lubmanDanielj hicklinCompany or werewolf nasdaqWerewolf therapeutics incScientific communicationsWerewolf therapeuticsChief executive officerChief medical officerBusiness officer werewolf